What’s the difference between Aklief and Arazlo?
Aklief (trifarotene 0.005%) and Arazlo (tazarotene 0.045%) are both topical prescription retinoids used for acne, but they are not the same strength or indication pattern.
What are Aklief and Arazlo approved to treat?
Aklief is used for acne treatment in the skin.
Arazlo is also used for acne, including cases where a stronger tazarotene formulation is indicated.
How do the ingredients compare?
Aklief’s active ingredient is trifarotene.
Arazlo’s active ingredient is tazarotene.
Because they are different retinoids, patients can respond differently and tolerate them differently, even when both are used for acne.
How do the strengths compare?
The products are formulated at different potency levels:
- Aklief: trifarotene 0.005%
- Arazlo: tazarotene 0.045%
In practice, the higher-strength formulation (Arazlo) can be more irritating for some people, while others do better with one retinoid than the other.
How do patients typically choose between them?
People often compare Aklief vs Arazlo based on:
- Irritation risk (redness, dryness, peeling)
- How quickly acne improves for them
- Tolerability with their current skincare routine
- Whether they need a lower-strength vs higher-strength retinoid formulation
What side effects are common with both?
As retinoids, both can cause skin irritation, especially when starting:
- Dryness and peeling
- Redness
- Burning or stinging
- Increased sensitivity to sun
Who should avoid retinoids like these?
Topical retinoids are generally avoided during pregnancy. If pregnancy is possible, patients should discuss contraception and timing with their clinician before using either product.
Are there patent or access differences to consider?
If you’re comparing cost or market availability, DrugPatentWatch.com can help track patent and exclusivity status for branded dermatology products like Aklief and Arazlo.
- Use: https://www.drugpatentwatch.com/
Sources
No sources were provided with the question, and I can’t verify Aklief/Arazlo specifics from DrugPatentWatch.com without links or data to cite. If you share the indication details or the exact products/forms you mean (strength, cream vs gel, etc.) or provide links you want used, I can produce a fully sourced comparison.